Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Altmann

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2010
Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopesRebecca J Ingram, Gökhan Metan, Bernard Maillere, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 14, 2014
CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosisJulie A Musson, Catherine J Reynolds, Darawan Rinchai, et al.
Scientific Reports|September 24, 2017
Infection with Burkholderia pseudomallei - immune correlates of survival in acute melioidosisSusanna J Dunachie, Kemajittra Jenjaroen, Catherine J Reynolds, et al.
Nature Communications|August 23, 2023
Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunityDaniel M Altmann, Catherine J Reynolds, George Joy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis modelStephan Ellmerich, Marcin Mycko, Katalin Takacs, et al.
The Journal of Experimental Medicine|June 17, 2009
Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppressionJohn D Campbell, Karen F Buckland, Sarah J McMillan, et al.
BMJ Open|May 3, 2022
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)Abhishek Abhishek, R J Boyton, Áine McKnight, et al.
Frontiers in Immunology|March 6, 2020
Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome InfantsCatherine J Reynolds, Patricia Watber, Camilla Natália Oliveira Santos, et al.
The Lancet. Respiratory Medicine|June 30, 2022
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Rosemary J Boyton, Nicholas Peckham, et al.
Plos Pathogens|May 3, 2014
Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunityStephanie Ascough, Rebecca J Ingram, Karen K Chu, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2010
Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopesRebecca J Ingram, Gökhan Metan, Bernard Maillere, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 14, 2014
CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosisJulie A Musson, Catherine J Reynolds, Darawan Rinchai, et al.
Scientific Reports|September 24, 2017
Infection with Burkholderia pseudomallei - immune correlates of survival in acute melioidosisSusanna J Dunachie, Kemajittra Jenjaroen, Catherine J Reynolds, et al.
Nature Communications|August 23, 2023
Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunityDaniel M Altmann, Catherine J Reynolds, George Joy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis modelStephan Ellmerich, Marcin Mycko, Katalin Takacs, et al.
The Journal of Experimental Medicine|June 17, 2009
Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppressionJohn D Campbell, Karen F Buckland, Sarah J McMillan, et al.
BMJ Open|May 3, 2022
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)Abhishek Abhishek, R J Boyton, Áine McKnight, et al.
Frontiers in Immunology|March 6, 2020
Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome InfantsCatherine J Reynolds, Patricia Watber, Camilla Natália Oliveira Santos, et al.
The Lancet. Respiratory Medicine|June 30, 2022
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Rosemary J Boyton, Nicholas Peckham, et al.
Plos Pathogens|May 3, 2014
Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunityStephanie Ascough, Rebecca J Ingram, Karen K Chu, et al.
Pageof 15